Laporan Laba Rugi (TTM)
Laporan Laba Rugi Krebs Biochemicals & Industries Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 495 | 516 | 527 | 489 | 432 | 554 | 597 | 636 | 715 | 588 | 521 | 521 | 460 | 499 | 504 | 527 | 507 | 492 | 433 | 359 |
| Change (%) | 4.10 | 2.15 | -7.21 | -11.72 | 28.34 | 7.79 | 6.51 | 12.50 | -17.78 | -11.36 | -0.11 | -11.62 | 8.44 | 1.03 | 4.58 | -3.86 | -2.98 | -11.94 | -17.10 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 462 | 495 | 516 | 506 | 501 | 653 | 441 | 770 | 834 | 695 | 277 | 185 | 92 | 89 | 94 | 75 | 107 | 107 | 100 | 46 |
| Change (%) | 7.21 | 4.24 | -2.01 | -0.85 | 30.33 | -32.47 | 74.53 | 8.35 | -16.69 | -60.13 | -33.15 | -50.15 | -3.81 | 5.79 | -20.42 | 42.50 | 0.30 | -6.18 | -54.27 | |
| % of Revenue | 93.19 | 95.97 | 97.94 | 103.42 | 116.15 | 117.95 | 73.90 | 121.09 | 116.63 | 118.18 | 53.16 | 35.58 | 20.07 | 17.80 | 18.64 | 14.18 | 21.02 | 21.74 | 23.16 | 12.78 |
| Gross Operating Profit | 34 | 21 | 11 | -17 | -70 | -99 | 156 | -134 | -119 | -107 | 244 | 335 | 368 | 410 | 410 | 452 | 400 | 385 | 333 | 313 |
| Change (%) | -38.46 | -47.66 | -253.62 | 317.38 | 42.62 | -256.76 | -186.04 | -11.31 | -10.10 | -328.38 | 37.38 | 9.66 | 11.52 | -0.01 | 10.30 | -11.52 | -3.85 | -13.54 | -5.90 | |
| % of Revenue | 6.81 | 4.03 | 2.06 | -3.42 | -16.15 | -17.95 | 26.10 | -21.09 | -16.63 | -18.18 | 46.84 | 64.42 | 79.93 | 82.20 | 81.36 | 85.82 | 78.98 | 78.26 | 76.84 | 87.22 |
| SG&A | 166 | 168 | 169 | 149 | 156 | 159 | 160 | 157 | 167 | 164 | 165 | 162 | 173 | 178 | 171 | 167 | 175 | 176 | 173 | 151 |
| Change (%) | 1.22 | 0.61 | -11.89 | 4.97 | 2.09 | 0.41 | -2.04 | 6.53 | -1.74 | 0.88 | -1.73 | 6.24 | 3.10 | -4.17 | -2.31 | 5.29 | 0.34 | -1.94 | -12.51 | |
| % of Revenue | 33.40 | 32.48 | 31.99 | 30.38 | 36.12 | 28.74 | 26.77 | 24.62 | 23.31 | 27.86 | 31.71 | 31.20 | 37.50 | 35.65 | 33.82 | 31.59 | 34.60 | 35.78 | 39.85 | 42.06 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 702 | 735 | 748 | 734 | 725 | 891 | 992 | 1,026 | 1,051 | 860 | 740 | 702 | 634 | 664 | 656 | 674 | 674 | 683 | 646 | 567 |
| Change (%) | 4.67 | 1.79 | -1.93 | -1.16 | 22.77 | 11.39 | 3.48 | 2.43 | -18.24 | -13.93 | -5.11 | -9.70 | 4.77 | -1.20 | 2.70 | 0.03 | 1.31 | -5.39 | -12.18 | |
| % of Revenue | 141.77 | 142.54 | 142.05 | 150.12 | 168.08 | 160.78 | 166.15 | 161.42 | 146.98 | 146.15 | 141.90 | 134.80 | 137.73 | 133.06 | 130.14 | 127.80 | 132.96 | 138.84 | 149.16 | 158.02 |
| Operating Income | -207 | -219 | -222 | -245 | -294 | -337 | -395 | -391 | -336 | -271 | -218 | -181 | -174 | -165 | -152 | -147 | -167 | -191 | -213 | -208 |
| Change (%) | 6.04 | 0.95 | 10.61 | 19.91 | 14.59 | 17.31 | -1.11 | -13.96 | -19.23 | -19.51 | -17.05 | -4.17 | -4.98 | -7.92 | -3.54 | 14.02 | 14.31 | 11.46 | -2.16 | |
| % of Revenue | -41.77 | -42.54 | -42.05 | -50.12 | -68.08 | -60.78 | -66.15 | -61.42 | -46.98 | -46.15 | -41.90 | -34.80 | -37.73 | -33.06 | -30.14 | -27.80 | -32.96 | -38.84 | -49.16 | -58.02 |
| Interest Expense | -61 | -58 | -63 | -66 | -62 | -66 | -54 | -42 | -32 | -23 | -30 | -38 | -42 | -44 | -47 | -49 | -52 | -56 | -59 | -62 |
| Change (%) | -4.44 | 7.24 | 4.57 | -5.43 | 6.36 | -18.38 | -22.30 | -23.48 | -28.90 | 30.53 | 26.77 | 10.35 | 6.93 | 5.45 | 4.79 | 5.85 | 7.13 | 6.12 | 5.72 | |
| % of Revenue | -12.35 | -11.34 | -11.90 | -13.42 | -14.37 | -11.91 | -9.02 | -6.58 | -4.48 | -3.87 | -5.70 | -7.23 | -9.03 | -8.90 | -9.29 | -9.31 | -10.25 | -11.32 | -13.64 | -17.40 |
| Net Income | -266 | -275 | -284 | -311 | -355 | -402 | -445 | -432 | -365 | -291 | -247 | -219 | -214 | -208 | -197 | -196 | -218 | -245 | -269 | -271 |
| Change (%) | 3.69 | 3.01 | 9.53 | 14.35 | 13.18 | 10.76 | -2.89 | -15.70 | -20.26 | -15.05 | -11.36 | -2.24 | -2.70 | -5.25 | -0.82 | 11.19 | 12.69 | 9.88 | 0.57 | |
| % of Revenue | -53.59 | -53.37 | -53.83 | -63.54 | -82.30 | -72.58 | -74.58 | -68.00 | -50.96 | -49.42 | -47.36 | -42.03 | -46.49 | -41.72 | -39.13 | -37.11 | -42.92 | -49.85 | -62.20 | -75.46 |
Source: Capital IQ
